AI Engines For more Details: Perplexity Kagi Labs You
Thyroid Disorders: Tiratricol has been investigated for its potential use in the treatment of thyroid disorders, including hypothyroidism and goiter. It can act as a thyroid hormone agonist, stimulating thyroid hormone receptors and promoting metabolic activity.
Metabolic Regulation: Like endogenous thyroid hormones (triiodothyronine or T3 and thyroxine or T4), tiratricol can influence metabolic processes in the body. It may affect basal metabolic rate, energy expenditure, lipid metabolism, and glucose homeostasis.
Weight Loss: Due to its effects on metabolism, tiratricol has been studied for its potential role in weight loss and obesity management. Some research suggests that it may increase energy expenditure and promote fat loss, although the evidence is limited, and its use for weight loss purposes is not widely accepted or recommended.
Athletic Performance Enhancement: In some cases, tiratricol has been used illicitly by athletes and bodybuilders seeking to enhance athletic performance or achieve lean body mass. However, the use of tiratricol for performance enhancement purposes is not approved and may pose serious health risks.
Research Applications: Tiratricol is also utilized in scientific research settings to investigate thyroid hormone signaling pathways, metabolic regulation, and related physiological processes. Its use in laboratory studies helps researchers better understand thyroid function and develop potential treatments for thyroid disorders and metabolic diseases.
Side Effects: Like other thyroid hormone derivatives, tiratricol may cause side effects, including cardiovascular effects such as palpitations, tachycardia (rapid heartbeat), and hypertension (high blood pressure). It can also lead to hyperthyroidism-like symptoms such as tremors, nervousness, sweating, and heat intolerance. Long-term use of tiratricol may potentially disrupt thyroid function and lead to thyroid hormone imbalances.
Regulatory Status: The use of tiratricol is regulated, and it may require a prescription or be available for research purposes only, depending on the jurisdiction. It is not approved for medical use in all countries, and its use should be supervised by a healthcare professional knowledgeable about thyroid disorders and endocrinology.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Bacteroides uniformis | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| 📓 Direct Citations | 👪👶 Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Bacteroides | genus | Increases |
| 1 | 0 | Bacteroides uniformis | species | Increases |
| 0 | 1 | Bacteroides uniformis ATCC 8492 | strain | Increases |
| 0 | 1 | Bacteroides uniformis CL03T00C23 | strain | Increases |
| 0 | 1 | Bacteroides uniformis dnLKV2 | strain | Increases |
| 0 | 1 | Bacteroides uniformis str. 3978 T3 i | strain | Increases |
| 0 | 1 | Bacteroides uniformis str. 3978 T3 ii | strain | Increases |
| 0 | 1 | Bacteroides uniformis CL03T12C37 | strain | Increases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 0.3 | -0.3 | |
| ADHD | 0.4 | -0.4 | |
| Allergic Rhinitis (Hay Fever) | 0.3 | -0.3 | |
| Allergies | 0.3 | 0.3 | |
| Allergy to milk products | 0.3 | 0.3 | 0 |
| Alzheimer's disease | 0.3 | 0.7 | -1.33 |
| Ankylosing spondylitis | 0.3 | 0.3 | 0 |
| Anorexia Nervosa | 0.3 | 0.3 | |
| Asthma | 0.3 | 0.3 | 0 |
| Atherosclerosis | 0.3 | -0.3 | |
| Atrial fibrillation | 0.3 | 0.3 | 0 |
| Autism | 0.3 | 0.3 | 0 |
| benign prostatic hyperplasia | 0.3 | 0.3 | |
| Bipolar Disorder | 0.3 | -0.3 | |
| Brain Trauma | 0.3 | 0.3 | |
| Carcinoma | 0.3 | 0.3 | 0 |
| Celiac Disease | 0.3 | 0.3 | 0 |
| Cerebral Palsy | 0.3 | 0.3 | 0 |
| Chronic Fatigue Syndrome | 0.3 | 0.7 | -1.33 |
| Chronic Kidney Disease | 0.3 | -0.3 | |
| Chronic Lyme | 0.3 | 0.3 | |
| Cognitive Function | 0.3 | -0.3 | |
| Colorectal Cancer | 0.3 | 0.3 | 0 |
| Constipation | 0.3 | -0.3 | |
| Coronary artery disease | 0.3 | 0.3 | |
| COVID-19 | 0.7 | 0.7 | 0 |
| Crohn's Disease | 0.3 | 0.7 | -1.33 |
| Cushing's Syndrome (hypercortisolism) | 0.3 | 0.3 | |
| cystic fibrosis | 0.3 | 0.3 | |
| deep vein thrombosis | 0.3 | 0.3 | |
| Depression | 0.3 | 0.7 | -1.33 |
| Endometriosis | 0.3 | -0.3 | |
| Epilepsy | 0.3 | 0.3 | 0 |
| erectile dysfunction | 0.3 | -0.3 | |
| Fibromyalgia | 0.7 | 0.7 | |
| Functional constipation / chronic idiopathic constipation | 0.3 | 0.3 | 0 |
| Generalized anxiety disorder | 0.3 | 0.3 | 0 |
| Gout | 0.3 | -0.3 | |
| Graves' disease | 0.3 | 0.3 | 0 |
| Halitosis | 0.3 | -0.3 | |
| Hashimoto's thyroiditis | 0.3 | 0.3 | 0 |
| Heart Failure | 0.3 | -0.3 | |
| Hidradenitis Suppurativa | 0.3 | -0.3 | |
| hyperglycemia | 0.3 | 0.3 | |
| hypertension (High Blood Pressure | 0.3 | 0.3 | 0 |
| Hypoxia | 0.3 | -0.3 | |
| IgA nephropathy (IgAN) | 0.4 | 0.3 | 0.33 |
| Inflammatory Bowel Disease | 0.3 | 0.3 | 0 |
| Insomnia | 0.3 | 0.3 | 0 |
| Intelligence | 0.7 | -0.7 | |
| Intracranial aneurysms | 0.3 | -0.3 | |
| Irritable Bowel Syndrome | 0.7 | 0.3 | 1.33 |
| ischemic stroke | 0.3 | 0.3 | 0 |
| Liver Cirrhosis | 0.3 | 0.3 | 0 |
| Long COVID | 0.3 | 0.3 | 0 |
| ME/CFS with IBS | 0.3 | 0.3 | |
| ME/CFS without IBS | 0.3 | 0.3 | |
| Metabolic Syndrome | 0.7 | 0.3 | 1.33 |
| Mood Disorders | 0.3 | 0.7 | -1.33 |
| Multiple Sclerosis | 0.3 | 0.3 | |
| neuropathic pain | 0.3 | 0.3 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 0.3 | 0 |
| NonCeliac Gluten Sensitivity | 0.3 | 0.3 | 0 |
| Obesity | 0.3 | 0.3 | 0 |
| obsessive-compulsive disorder | 0.3 | 0.7 | -1.33 |
| Osteoarthritis | 0.3 | 0.7 | -1.33 |
| Osteoporosis | 0.3 | 0.3 | 0 |
| Parkinson's Disease | 0.3 | 0.3 | 0 |
| Polycystic ovary syndrome | 0.3 | 0.3 | 0 |
| primary biliary cholangitis | 0.4 | 0.4 | |
| Primary sclerosing cholangitis | 0.3 | -0.3 | |
| Psoriasis | 0.3 | 0.3 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 0.3 | 0 |
| Schizophrenia | 0.3 | 0.7 | -1.33 |
| Sjögren syndrome | 0.7 | 0.7 | |
| Sleep Apnea | 0.3 | 0.3 | |
| Slow gastric motility / Gastroparesis | 0.3 | -0.3 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | -0.3 | |
| Stress / posttraumatic stress disorder | 0.3 | 0.3 | 0 |
| Systemic Lupus Erythematosus | 0.3 | -0.3 | |
| Tourette syndrome | 0.3 | 0.3 | |
| Type 1 Diabetes | 0.3 | 0.3 | 0 |
| Type 2 Diabetes | 0.7 | 0.3 | 1.33 |
| Ulcerative colitis | 0.7 | 0.3 | 1.33 |
| Unhealthy Ageing | 0.3 | -0.3 | |
| Vitiligo | 0.3 | -0.3 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
